1887

Microbiology Society logo

Volume 157, Issue 7

strains replicate and persist in the murine lung, but to significantly different degrees Free

Abstract

The environmental bacterium is increasingly described as a multidrug-resistant pathogen of humans, being associated with pneumonia, among other diseases. But the degree to which is capable of replicating in a mammalian host has been an issue of controversy. Using a model of intranasal inoculation into adult A/J mice, we now document that strain K279a, the clinical isolate of whose complete genome sequence was recently determined, is in fact capable of replicating in lungs, displaying as much as a 10-fold increase in c.f.u. in the first 8 h of infection. Importantly, as few as 10 c.f.u. deposited into the A/J lung was sufficient to promote bacterial outgrowth. Bacterial replication in the lungs of the A/J mice was followed by elevations in pro-inflammatory cytokines and also promoted resistance to subsequent challenge. We also found that DBA/2 mice were permissive for K279a replication, although the level of growth and persistence in these animals was less than it was in the A/J mice. In contrast, the BALB/c and C57BL/6 mouse strains were non-permissive for K279a growth. Interestingly, when five additional clinical isolates were introduced into the A/J lung, marked differences in survival were observed, with some strains being much less infective than K279a and others being appreciably more infective. These data suggest that the presence of major virulence determinants is variable among clinical isolates. Overall, this study confirms the infectivity of for the mammalian host, and illustrates how both host and bacterial factors affect the outcome of infection.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Funding
This study was supported by the:
  • NIH (Award R21 AI076693 and R03 AI082541)
© 2011 SGM
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.048157-0
2011-07-01
2024-04-30
Loading full text...

Full text loading...

/deliver/fulltext/micro/157/7/2133.html?itemId=/content/journal/micro/10.1099/mic.0.048157-0&mimeType=html&fmt=ahah

References

  1. Ahn S. H., Deshmukh H., Johnson N., Cowell L. G., Rude T. H., Scott W. K., Nelson C. L., Zaas A. K., Marchuk D. A. et al. ( 2010). Two genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analyses. PLoS Pathog 6:e1001088 [View Article][PubMed]
     [Google Scholar]
  2. Alonso A., Martínez J. L. ( 2000). Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44:3079–3086 [View Article][PubMed]
     [Google Scholar]
  3. Ansari S. R., Hanna H., Hachem R., Jiang Y., Rolston K., Raad I. ( 2007). Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 109:2615–2622 [View Article][PubMed]
     [Google Scholar]
  4. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. ( 1989). Current Protocols in Molecular Biology New York: Wiley;
     [Google Scholar]
  5. Avison M. B., von Heldreich C. J., Higgins C. S., Bennett P. M., Walsh T. R. ( 2000). A TEM-2 β-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother 46:879–884 [View Article][PubMed]
     [Google Scholar]
  6. Avison M. B., Higgins C. S., Ford P. J., von Heldreich C. J., Walsh T. R., Bennett P. M. ( 2002). Differential regulation of L1 and L2 β-lactamase expression in Stenotrophomonas maltophilia. J Antimicrob Chemother 49:387–389 [View Article][PubMed]
     [Google Scholar]
  7. Brieland J., Freeman P., Kunkel R., Chrisp C., Hurley M., Fantone J., Engleberg C. ( 1994). Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease. Am J Pathol 145:1537–1546[PubMed]
     [Google Scholar]
  8. Crossman L. C., Gould V. C., Dow J. M., Vernikos G. S., Okazaki A., Sebaihia M., Saunders D., Arrowsmith C., Carver T. et al. ( 2008). The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9:R74 [View Article][PubMed]
     [Google Scholar]
  9. Davies J. C., Rubin B. K. ( 2007). Emerging and unusual Gram-negative infections in cystic fibrosis. Semin Respir Crit Care Med 28:312–321 [View Article][PubMed]
     [Google Scholar]
  10. DebRoy S., Dao J., Söderberg M., Rossier O., Cianciotto N. P. ( 2006). Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung. Proc Natl Acad Sci U S A 103:19146–19151 [View Article][PubMed]
     [Google Scholar]
  11. Denton M., Kerr K. G. ( 1998). Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57–80[PubMed]
     [Google Scholar]
  12. Di Bonaventura G., Prosseda G., Del Chierico F., Cannavacciuolo S., Cipriani P., Petrucca A., Superti F., Ammendolia M. G., Concato C. et al. ( 2007). Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol 20:529–537[PubMed]
     [Google Scholar]
  13. Di Bonaventura G., Pompilio A., Zappacosta R., Petrucci F., Fiscarelli E., Rossi C., Piccolomini R. ( 2010). Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. Infect Immun 78:2466–2476 [View Article][PubMed]
     [Google Scholar]
  14. Falagas M. E., Kastoris A. C., Vouloumanou E. K., Dimopoulos G. ( 2009). Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur J Clin Microbiol Infect Dis 28:719–730 [View Article][PubMed]
     [Google Scholar]
  15. Figueirêdo P. M., Furumura M. T., Santos A. M., Sousa A. C., Kota D. J., Levy C. E., Yano T. ( 2006). Cytotoxic activity of clinical Stenotrophomonas maltophilia. Lett Appl Microbiol 43:443–449 [View Article][PubMed]
     [Google Scholar]
  16. Fouhy Y., Scanlon K., Schouest K., Spillane C., Crossman L., Avison M. B., Ryan R. P., Dow J. M. ( 2007). Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol 189:4964–4968 [View Article][PubMed]
     [Google Scholar]
  17. George S. E., Kohan M. J., Gilmour M. I., Taylor M. S., Brooks H. G., Creason J. P., Claxton L. D. ( 1993). Pulmonary clearance and inflammatory response in C3H/HeJ mice after intranasal exposure to Pseudomonas spp. Appl Environ Microbiol 59:3585–3591[PubMed]
     [Google Scholar]
  18. Glomski I. J., Dumetz F., Jouvion G., Huerre M. R., Mock M., Goossens P. L. ( 2008). Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect 10:1398–1404 [View Article][PubMed]
     [Google Scholar]
  19. Gordon N. C., Wareham D. W. ( 2010). Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 65:483–489 [View Article][PubMed]
     [Google Scholar]
  20. Gould V. C., Avison M. B. ( 2006). SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J Antimicrob Chemother 57:1070–1076 [View Article][PubMed]
     [Google Scholar]
  21. Hernández A., Maté M. J., Sánchez-Díaz P. C., Romero A., Rojo F., Martínez J. L. ( 2009). Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. J Biol Chem 284:14428–14438 [View Article][PubMed]
     [Google Scholar]
  22. Huang T. P., Wong A. C. ( 2007). A cyclic AMP receptor protein-regulated cell-cell communication system mediates expression of a FecA homologue in Stenotrophomonas maltophilia. Appl Environ Microbiol 73:5034–5040 [View Article][PubMed]
     [Google Scholar]
  23. Huang Y. W., Lin C. W., Hu R. M., Lin Y. T., Chung T. C., Yang T. C. ( 2010). AmpN-AmpG operon is essential for expression of L1 and L2 β-lactamases in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 54:2583–2589 [View Article][PubMed]
     [Google Scholar]
  24. Kim H. B., Srinivasan S., Sathiyaraj G., Quan L. H., Kim S. H., Bui T. P., Liang Z. Q., Kim Y. J., Yang D. C. ( 2010). Stenotrophomonas ginsengisoli sp. nov., isolated from a ginseng field. Int J Syst Evol Microbiol 60:1522–1526 [View Article][PubMed]
     [Google Scholar]
  25. Lambiase A., Raia V., Del Pezzo M., Sepe A., Carnovale V., Rossano F. ( 2006). Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis 6:4–10 [View Article][PubMed]
     [Google Scholar]
  26. Lee M., Woo S. G., Chae M., Shin M. C., Jung H. M., Ten L. N. ( 2011). Stenotrophomonas daejeonensis sp. nov., isolated from sewage. Int J Syst Evol Microbiol 61:598–604 [View Article][PubMed]
     [Google Scholar]
  27. Looney W. J., Narita M., Mühlemann K. ( 2009). Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312–323 [View Article][PubMed]
     [Google Scholar]
  28. McKay G. A., Woods D. E., MacDonald K. L., Poole K. ( 2003). Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun 71:3068–3075 [View Article][PubMed]
     [Google Scholar]
  29. Minkwitz A., Berg G. ( 2001). Comparison of antifungal activities and 16S ribosomal DNA sequences of clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol 39:139–145 [View Article][PubMed]
     [Google Scholar]
  30. Nicoletti M., Iacobino A., Prosseda G., Fiscarelli E., Zarrilli R., De Carolis E., Petrucca A., Nencioni L., Colonna B., Casalino M. ( 2011). Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol 301:34–43 [View Article][PubMed]
     [Google Scholar]
  31. Okazaki A., Avison M. B. ( 2007). Aph(3′)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 51:359–360 [View Article][PubMed]
     [Google Scholar]
  32. Paez J. I., Tengan F. M., Barone A. A., Levin A. S., Costa S. F. ( 2008). Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 27:901–906 [View Article][PubMed]
     [Google Scholar]
  33. Paschoal I. A., de Oliveira Villalba W., Bertuzzo C. S., Cerqueira E. M., Pereira M. C. ( 2007). Cystic fibrosis in adults. Lung 185:81–87 [View Article][PubMed]
     [Google Scholar]
  34. Qiu H., KuoLee R., Harris G., Chen W. ( 2009). High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect 11:946–955 [View Article][PubMed]
     [Google Scholar]
  35. Ricklin D., Hajishengallis G., Yang K., Lambris J. D. ( 2010). Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785–797 [View Article][PubMed]
     [Google Scholar]
  36. Rocco F., De Gregorio E., Colonna B., Di Nocera P. P. ( 2009). Stenotrophomonas maltophilia genomes: a start-up comparison. Int J Med Microbiol 299:535–546 [View Article][PubMed]
     [Google Scholar]
  37. Rossier O., Starkenburg S. R., Cianciotto N. P. ( 2004). Legionella pneumophila type II protein secretion promotes virulence in the A/J mouse model of Legionnaires' disease pneumonia. Infect Immun 72:310–321 [View Article][PubMed]
     [Google Scholar]
  38. Ryan R. P., Monchy S., Cardinale M., Taghavi S., Crossman L., Avison M. B., Berg G., van der Lelie D., Dow J. M. ( 2009). The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol 7:514–525 [View Article][PubMed]
     [Google Scholar]
  39. Safdar A., Rolston K. V. ( 2007). Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45:1602–1609 [View Article][PubMed]
     [Google Scholar]
  40. Sánchez M. B., Martínez J. L. ( 2010). SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 54:580–581 [View Article][PubMed]
     [Google Scholar]
  41. Sánchez M. B., Hernández A., Rodríguez-Martínez J. M., Martínez-Martínez L., Martínez J. L. ( 2008). Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol 8:148 [View Article][PubMed]
     [Google Scholar]
  42. Sánchez M. B., Hernandez A., Martinez J. L. ( 2009). Stenotrophomonas maltophilia drug resistance. Future Microbiol 4:655–660 [View Article][PubMed]
     [Google Scholar]
  43. Schaumann R., Laurin F., Rodloff A. C. ( 2008). Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprinting. Int J Hyg Environ Health 211:292–298 [View Article][PubMed]
     [Google Scholar]
  44. Shimizu K., Kikuchi K., Sasaki T., Takahashi N., Ohtsuka M., Ono Y., Hiramatsu K. ( 2008). Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 52:3823–3825 [View Article][PubMed]
     [Google Scholar]
  45. Spicuzza L., Sciuto C., Vitaliti G., Di Dio G., Leonardi S., La Rosa M. ( 2009). Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur J Clin Microbiol Infect Dis 28:191–195 [View Article][PubMed]
     [Google Scholar]
  46. Travassos L. H., Pinheiro M. N., Coelho F. S., Sampaio J. L., Merquior V. L., Marques E. A. ( 2004). Phenotypic properties, drug susceptibility and genetic relatedness of Stenotrophomonas maltophilia clinical strains from seven hospitals in Rio de Janeiro, Brazil. J Appl Microbiol 96:1143–1150 [View Article][PubMed]
     [Google Scholar]
  47. Valdezate S., Vindel A., Martín-Dávila P., Del Saz B. S., Baquero F., Cantón R. ( 2004). High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 42:693–699 [View Article][PubMed]
     [Google Scholar]
  48. Waters V. J., Gómez M. I., Soong G., Amin S., Ernst R. K., Prince A. ( 2007). Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect Immun 75:1698–1703 [View Article][PubMed]
     [Google Scholar]
  49. Waters V., Yau Y., Prasad S., Lu A., Atenafu E., Crandall I., Tom S., Tullis E., Ratjen F. ( 2011). Stenotrophomonas maltophilia in cystic fibrosis: Serologic response and effect on lung disease. Am J Respir Crit Care Med 183:635–640 [View Article][PubMed]
     [Google Scholar]
  50. Wilson K. R., Napper J. M., Denvir J., Sollars V. E., Yu H. D. ( 2007). Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology 153:968–979 [View Article][PubMed]
     [Google Scholar]
  51. Yi H., Srinivasan S., Kim M. K. ( 2010). Stenotrophomonas panacihumi sp. nov., isolated from soil of a ginseng field. J Microbiol 48:30–35 [View Article][PubMed]
     [Google Scholar]
  52. Zamboni D. S., Kobayashi K. S., Kohlsdorf T., Ogura Y., Long E. M., Vance R. E., Kuida K., Mariathasan S., Dixit V. M. et al. ( 2006). The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 7:318–325 [View Article][PubMed]
     [Google Scholar]
  53. Zgair A. K., Chhibber S. ( 2010a). Immunological and pathological aspects of respiratory tract infection with Stenotrophomonas maltophilia in BALB/c mice. J Microbiol Biotechnol 20:1585–1591 [View Article][PubMed]
     [Google Scholar]
  54. Zgair A. K., Chhibber S. ( 2010b). Stenotrophomonas maltophilia flagellin induces a compartmentalized innate immune response in mouse lung. J Med Microbiol 59:913–919 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.048157-0
Loading
Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees
Microbiology 157, 2133 (2011); https://doi.org/10.1099/mic.0.048157-0
/content/journal/micro/10.1099/mic.0.048157-0
/content/journal/micro/10.1099/mic.0.048157-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error